The effectiveness of cyproheptadine in the treatment of acute akathisia caused by neuroleptics

Phase 3

• Conditions: Akathisia.; Drug induced akathisia; G25.71

• Registration Number: IRCT20191218045795N7
• Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Get antipsychotic
A minimum score of 2 on the akathisia scale BARS

Exclusion Criteria

Receiving beta blocker, mianserin, cyproheptadine, vitamin B6
Suiccidal thoughtsevere
Severe akathisia (score higher than 5 in BARS)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BARS akathisia score. Timepoint: At the beginning of the study (before the start of the intervention) and 5 days after the start of cyproheptadine. Method of measurement: BARS akathisia questionaire.